Career history of Gabriele Elbl
Former positions of Gabriele Elbl
| Companies | Position | Start | End |
|---|---|---|---|
| MORPHOSYS AG | General Counsel | 19/12/2013 | 01/10/2018 |
| THOR MEDICAL | General Counsel | 01/11/2019 | - |
| HEIDELBERG PHARMA AG | General Counsel | 28/05/2010 | - |
| Corporate Officer/Principal | 27/05/2010 | 28/05/2010 |
Training of Gabriele Elbl
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistics
International
| Germany | 4 |
| Norway | 2 |
Operational
| General Counsel | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| HEIDELBERG PHARMA AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| Private companies | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Gabriele Elbl
- Experience
